Literature DB >> 18187567

Vanin-1 pantetheinase drives increased chondrogenic potential of mesenchymal precursors in ank/ank mice.

Kristen A Johnson1, Wei Yao, Nancy E Lane, Philippe Naquet, Robert A Terkeltaub.   

Abstract

Widespread endochondral and intramembranous ectopic bone formation is mediated by extracellular PP(i) deficiency that develops in ank/ank mice. Herein we report on the rapid condensation into chondrogenic nodules of cultured ank/ank bone marrow stromal cells (BMSCs). We compared the roles of increased chondrogenic potential versus altered osteoblast function in the ank/ank phenotype. To do so, we crossbred ank/ank mice with mice lacking Vanin-1 pantetheinase, which inhibits synthesis of the chondrogenesis regulator glutathione, since we observed increased Vanin-1 expression and pantetheinase activity and decreased glutathione in ank/ank BMSCs. Vnn1(-/-) BMSCs demonstrated delayed chondrogenesis mediated by increased glutathione. Moreover, increased chondrogenesis of ank/ank BMSCs and increased chondrogenic transdifferentiation and calcification by ank/ank aortic smooth muscle cells and explants were corrected by Vanin-1 knockout. Osteoblastogenesis was accelerated in ank/ank mesenchymal stem cells. However, in cultured ank/ank osteoblasts, Vanin-1 knockout actually increased specific alkaline phosphatase activity and lowered extracellular PP(i), and did not correct increased calcification. Moreover, Vanin-1 knockout failed to correct the ank/ank skeletal soft tissue phenotype. Therefore, ank/ank periskeletal soft tissue calcification appears more dependent on altered osteoblastic function than enhanced chondrogenic potential and is not dependent on Vanin-1; however, Vanin-1 regulates chondrogenesis via glutathione metabolism and is critical for accelerated chondrogenesis of ank/ank mesenchymal precursors and P(i) donor-driven chondrogenic transdifferentiation and calcification of aortic smooth muscle cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18187567      PMCID: PMC2312367          DOI: 10.2353/ajpath.2008.070753

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  54 in total

1.  Therapeutic effects of cystamine in a murine model of Huntington's disease.

Authors:  Alpaslan Dedeoglu; James K Kubilus; Thomas M Jeitner; Samantha A Matson; Misha Bogdanov; Neil W Kowall; Wayne R Matson; Arthur J L Cooper; Rajiv R Ratan; M Flint Beal; Steven M Hersch; Robert J Ferrante
Journal:  J Neurosci       Date:  2002-10-15       Impact factor: 6.167

2.  Proteoglycan production by immortalized human chondrocyte cell lines cultured under conditions that promote expression of the differentiated phenotype.

Authors:  R Kokenyesi; L Tan; J R Robbins; M B Goldring
Journal:  Arch Biochem Biophys       Date:  2000-11-01       Impact factor: 4.013

3.  The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6.

Authors:  Haruhiko Akiyama; Marie-Christine Chaboissier; James F Martin; Andreas Schedl; Benoit de Crombrugghe
Journal:  Genes Dev       Date:  2002-11-01       Impact factor: 11.361

4.  AP-1 transcription factor complex is a target of signals from both WnT-7a and N-cadherin-dependent cell-cell adhesion complex during the regulation of limb mesenchymal chondrogenesis.

Authors:  A Cevik Tufan; Kathleen M Daumer; Anthony M DeLise; Rocky S Tuan
Journal:  Exp Cell Res       Date:  2002-02-15       Impact factor: 3.905

5.  Altered differentiation in rat and rabbit limb bud micromass cultures by glutathione modulating agents.

Authors:  J M Hansen; E W Carney; C Harris
Journal:  Free Radic Biol Med       Date:  2001-12-15       Impact factor: 7.376

6.  Vanin genes are clustered (human 6q22-24 and mouse 10A2B1) and encode isoforms of pantetheinase ectoenzymes.

Authors:  F Martin; F Malergue; G Pitari; J M Philippe; S Philips; C Chabret; S Granjeaud; M G Mattei; A J Mungall; P Naquet; F Galland
Journal:  Immunogenetics       Date:  2001 May-Jun       Impact factor: 2.846

7.  Mobilized bone marrow cells repair the infarcted heart, improving function and survival.

Authors:  D Orlic; J Kajstura; S Chimenti; F Limana; I Jakoniuk; F Quaini; B Nadal-Ginard; D M Bodine; A Leri; P Anversa
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-14       Impact factor: 11.205

8.  Pantetheinase activity of membrane-bound Vanin-1: lack of free cysteamine in tissues of Vanin-1 deficient mice.

Authors:  G Pitari; F Malergue; F Martin; J M Philippe; M T Massucci; C Chabret; B Maras; S Duprè; P Naquet; F Galland
Journal:  FEBS Lett       Date:  2000-10-20       Impact factor: 4.124

9.  Wnt-3A enhances bone morphogenetic protein-2-mediated chondrogenesis of murine C3H10T1/2 mesenchymal cells.

Authors:  Leslie Fischer; Genevieve Boland; Rocky S Tuan
Journal:  J Biol Chem       Date:  2002-06-20       Impact factor: 5.157

10.  Tissue-nonspecific alkaline phosphatase and plasma cell membrane glycoprotein-1 are central antagonistic regulators of bone mineralization.

Authors:  Lovisa Hessle; Kristen A Johnson; H Clarke Anderson; Sonoko Narisawa; Adnan Sali; James W Goding; Robert Terkeltaub; José Luis Millan
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-24       Impact factor: 11.205

View more
  14 in total

1.  Arterial calcification is driven by RAGE in Enpp1-/- mice.

Authors:  Denise L Cecil; Robert A Terkeltaub
Journal:  J Vasc Res       Date:  2010-11-23       Impact factor: 1.934

2.  Granulin epithelin precursor: a bone morphogenic protein 2-inducible growth factor that activates Erk1/2 signaling and JunB transcription factor in chondrogenesis.

Authors:  Jian Q Feng; Feng-Jin Guo; Bai-Chun Jiang; Yan Zhang; Sally Frenkel; Da-Wei Wang; Wei Tang; Yixia Xie; Chuan-Ju Liu
Journal:  FASEB J       Date:  2010-02-02       Impact factor: 5.191

Review 3.  Genetics in arterial calcification: pieces of a puzzle and cogs in a wheel.

Authors:  Frank Rutsch; Yvonne Nitschke; Robert Terkeltaub
Journal:  Circ Res       Date:  2011-08-19       Impact factor: 17.367

4.  Enhanced hepatotoxicity by acetaminophen in Vanin-1 knockout mice is associated with deficient proliferative and immune responses.

Authors:  Daniel W Ferreira; Michael J Goedken; Samuel Rommelaere; Lionel Chasson; Franck Galland; Philippe Naquet; José E Manautou
Journal:  Biochim Biophys Acta       Date:  2016-02-02

5.  Chondrocyte AMP-activated protein kinase activity suppresses matrix degradation responses to proinflammatory cytokines interleukin-1β and tumor necrosis factor α.

Authors:  Robert Terkeltaub; Bing Yang; Martin Lotz; Ru Liu-Bryan
Journal:  Arthritis Rheum       Date:  2011-07

6.  Hypophosphatemia, hyperphosphaturia, and bisphosphonate treatment are associated with survival beyond infancy in generalized arterial calcification of infancy.

Authors:  Frank Rutsch; Petra Böyer; Yvonne Nitschke; Nico Ruf; Bettina Lorenz-Depierieux; Tanja Wittkampf; Gabriele Weissen-Plenz; Rudolf-Josef Fischer; Zulf Mughal; John W Gregory; Justin H Davies; Chantal Loirat; Tim M Strom; Dirk Schnabel; Peter Nürnberg; Robert Terkeltaub
Journal:  Circ Cardiovasc Genet       Date:  2008-12

7.  The pattern recognition receptor CD36 is a chondrocyte hypertrophy marker associated with suppression of catabolic responses and promotion of repair responses to inflammatory stimuli.

Authors:  Denise L Cecil; C Thomas G Appleton; Monika D Polewski; John S Mort; Ann Marie Schmidt; Alison Bendele; Frank Beier; Robert Terkeltaub
Journal:  J Immunol       Date:  2009-04-15       Impact factor: 5.422

8.  XBP1S associates with RUNX2 and regulates chondrocyte hypertrophy.

Authors:  Yanna Liu; Jinghua Zhou; Wenjun Zhao; Xiangzhu Li; Rong Jiang; Chuanju Liu; Feng-Jin Guo
Journal:  J Biol Chem       Date:  2012-08-03       Impact factor: 5.157

9.  Phosphate and pyrophosphate mediate PKA-induced vascular cell calcification.

Authors:  Michael S Huang; Andrew P Sage; Jinxiu Lu; Linda L Demer; Yin Tintut
Journal:  Biochem Biophys Res Commun       Date:  2008-07-23       Impact factor: 3.575

Review 10.  Regulation of coenzyme A levels by degradation: the 'Ins and Outs'.

Authors:  Philippe Naquet; Evan W Kerr; Schuyler D Vickers; Roberta Leonardi
Journal:  Prog Lipid Res       Date:  2020-03-29       Impact factor: 16.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.